Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

A newly found RNA in Cashmere goats may play a role in hair growth and development.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

Most patients stop using topical minoxidil due to side effects.

No link found between aromatase gene and female hair loss.

More than half of patients who had acromegaly surgery experienced hair loss, with varying degrees of recovery.

The study suggests pandemic stress might worsen or trigger hair loss problems.

Finasteride use is not clearly linked to an increased risk of male breast cancer.

About one-third of Saudi women with female pattern hair loss also have thinning hair at the back of their head.

Young, lower-income men are more likely to visit the emergency department for severe sunburns, especially in the summer and on weekends.

Many survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Togo suffer long-term eye and skin problems.

PRP injections improve hair thickness for baldness.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

10% carbamide peroxide is safe and effectively reduces mild to moderate acne.

Laser treatment may help with hair growth in some people with frontal fibrosing alopecia, but results vary and the exact way it works is unclear.

Most patients with cutaneous dermatomyositis either improved or remained stable over 3.5 years.

People with hidradenitis suppurativa who are more resilient tend to have better quality of life and less anxiety and depression.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Doctors vary in how they initially test for PCOS, but most agree on using oral contraceptives and lifestyle changes as first treatments.

Androgen levels do not determine the type of PCOS symptoms in young females.